Blockade of cannabinoid CB1 receptors potentiates the anti‐fibrotic effects mediated by SGLT2 inhibition in a mouse model of diabetic nephropathy. - Pointeau, Océane; Ba, Awa Isma; Geissler, Audrey; Barbosa, Romain; Basu, Abhishek; Muhammad, Arif; Nivot, Marina; Loriot, Maéva; Leemput, Julia; Passilly‐Degrace, Patricia; Causse, Sébastien; Demizieux, Laurent; et al. (British Journal of Pharmacology, 2025)